CHANEX

Welcome to the Brand page for “CHANEX”, which is offered here for Clinical, medical reagents for use in the gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing liposome reagents suitable for gene therapy; therapeutic compositions containing nucleic acids for gene therapy; pharmaceutical preparations containing nucleic acid for use in the treatment of cancer, hiv and aids related infections and bodily conditions associated with impaired immunosystems; viral and bacterial diseases, cancer and cystic fibrosis, pharmaceutic preparations in the field of gene therapy, pharmaceutics preparations for the treatment of cystic fibrosis;instruments and apparatus for the administration of gene therapy, syringes, scalpels, catheters, tubes for the administration of gene therapy products; surgical and medical apparatus and instruments, syringes, scalpels, catheters and tubes for medical services;.

Its status is currently believed to be active. Its class is unavailable. “CHANEX” is believed to be currently owned by “Oxford BioMedica plc”.